Z. Welsh

Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology

O. Kordonouri, T. Danne, J. Bugler, 2009, Diabetologia.

Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies

M. Evans, Z. Welsh, A. Seibold, 2022, Diabetes Therapy.

Maximum Residue Levels: Fact or Fiction?

Ian Pate, Kieran Hyder, Kim Z. Travis, 2003 .

Performance of a new test strip for freestyle blood glucose monitoring systems.

Ronald Brazg, Mona Patel, Shridhara Alva, 2011, Diabetes technology & therapeutics.

The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies

M. Evans, Z. Welsh, A. Seibold, 2019, Diabetes Therapy.

The role of the benchmark dose in a regulatory context.

Kim Z Travis, Ian Pate, Zoe K Welsh, 2005, Regulatory toxicology and pharmacology : RTP.

‘Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia: Comments on J. J. Isitt et al.’

Z. Welsh, R. Hellmund, 2022, Diabetic medicine : a journal of the British Diabetic Association.